BusinessVoyager Therapeutics Reports First Quarter 2017 Financial Results and Corporate HighlightsBy Nasdaq OMXMay 9, 2017, 8:14 PM UTC
BusinessVoyager Therapeutics Reports First Quarter 2017 Financial Results and Corporate HighlightsBy Nasdaq OMXMay 9, 2017, 8:14 PM UTC
BusinessVoyager Therapeutics Announces Additional Results from Phase 1b Trial of VY-AADC01 for Advanced Parkinson’s DiseaseBy Nasdaq OMXApr 25, 2017, 11:02 AM UTC